Search

Your search keyword '"Shiao,Tsu-Hui"' showing total 24 results
Start Over Author "Shiao,Tsu-Hui"
24 results on '"Shiao,Tsu-Hui"'

9. Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients

Author

Wang, Ting-Wei, primary, Chao, Heng-Sheng, additional, Chiu, Hwa-Yen, additional, Lin, Yi-Hui, additional, Chen, Hung-Chun, additional, Lu, Chia-Feng, additional, Liao, Chien-Yi, additional, Lee, Yen, additional, Shiao, Tsu-Hui, additional, Chen, Yuh-Min, additional, Huang, Jing-Wen, additional, and Wu, Yu-Te, additional

Published
2023
Full Text
View/download PDF

10. Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan

Author

Wu, Yuan‐Hung, primary, Kang, Yu‐Mei, additional, Hu, Yu‐Wen, additional, Lan, Keng‐Li, additional, Yen, Sang‐Hue, additional, Lai, Tzu‐Yu, additional, Lan, Tien‐Li, additional, Chen, Yuh‐Min, additional, Chiu, Chao‐Hua, additional, Luo, Yung‐Hung, additional, Chao, Heng‐sheng, additional, Chiang, Chi‐Lu, additional, Shiao, Tsu‐Hui, additional, Yang, Chao‐Neng, additional, Hsu, Wen‐Hu, additional, Wu, Yu‐Chung, additional, Hsu, Han‐Shui, additional, Hung, Jung‐Jyh, additional, Huang, Chien‐Sheng, additional, Hsu, Po‐Kuei, additional, and Chen, Yi‐Wei, additional

Published
2023
Full Text
View/download PDF

12. Additional file 1 of A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer

Author

Lu, Chia-Feng, Liao, Chien-Yi, Chao, Heng-Sheng, Chiu, Hwa-Yen, Wang, Ting-Wei, Lee, Yen, Chen, Jyun-Ru, Shiao, Tsu-Hui, Chen, Yuh-Min, and Wu, Yu-Te

Abstract

Additional file 1: Table S1. The formulae for the calculation of primary radiomic features. Table S2. Grid search results of DeepSurv hyper-parameters. Table S3. Comparisons of clinical characteristics between training and test sets. Table S4. Characteristics of clinical laboratory test. Table S5. Identified features for the model training in each DeepSurv model. Figure S1. The architecture of applied DeepSurv model. Figure S2. Schematic diagram of predictive risk-of-progression period in DeepSurv model.

Published
2023
Full Text
View/download PDF

16. Clinical Characteristics of Rapid Eye Movement-Related Obstructive Sleep Apnea: An Experience in a Tertiary Medical Center of Taiwan

Author

Chiu,Hwa-Yen, Liu,Yung-Yang, Shiao,Tsu-Hui, Su,Kang-Cheng, Chou,Kun-Ta, Chen,Yuh-Min, Chiu,Hwa-Yen, Liu,Yung-Yang, Shiao,Tsu-Hui, Su,Kang-Cheng, Chou,Kun-Ta, and Chen,Yuh-Min

Abstract

Hwa-Yen Chiu,1– 4 Yung-Yang Liu,1,4 Tsu-Hui Shiao,1,4 Kang-Cheng Su,1,4 Kun-Ta Chou,1,4 Yuh-Min Chen1,4 1Chest Department, Taipei Veterans General Hospital, Taipei, 11217, Taiwan, Republic of China; 2Institute of Biophotonics, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan, Republic of China; 3Division of Internal Medicine, Hsinchu Branch, Taipei Veterans General Hospital, Hsinchu, 31064, Taiwan, Republic of China; 4School of Medicine, Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan, Republic of ChinaCorrespondence: Yung-Yang Liu, Chest Department, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Beitou District, Taipei City, 11217, Taiwan, Republic of China, Tel +886-2-2871-2121 ext. 3071, Fax +886-2-2875-7858, Email yyliu1103@gmail.comPurpose: Obstructive sleep apnea (OSA) is characterized by intermittent hypoxemia and sleep fragmentation. While apnea is pronounced with severe desaturation during rapid eye movement (REM) sleep, REM-related OSA is a distinct phenotype of OSA associated with respiratory disturbances predominantly during REM sleep. In this study, we investigated the clinical features of REM-related OSA in Taiwan.Patients and Methods: All patients diagnosed with OSA in the Taipei Veterans General Hospital from 2015 to 2017 were analyzed retrospectively and classified into REM-related OSA (REM-OSA) group, non-REM related OSA (NREM-OSA) group, and non-stage specific-OSA group. The clinical demographics, OSA-related symptoms, polysomnography results, and medical comorbidities of the three groups were analyzed.Results: Among 1331 patients with OSA, 414 (31.1%) were classified as REM-OSA, 808 (60.7%) as NREM-OSA, and 109 (8.2%) as non-stage specific-OSA. After being adjusted for OSA severity, the REM-OSA group was associated with less portion of males, longer desaturation duration, and lower nadir oxygen saturation (SpO2) compared with the NREM-OSA group in mild and moderate OSA. In moderat

Published
2022

24. Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy.

Author

Shen, Chia-I, Huang, Hsu-Ching, Chiang, Chi-Lu, Luo, Yung-Hung, Shiao, Tsu-Hui, and Chiu, Chao-Hua

Subjects
*EPIDERMAL growth factor receptors, *PROGRESSION-free survival, *TREATMENT effectiveness, *PROTEIN-tyrosine kinases
Abstract

• Though regular brain MRI detected metastasis earlier, overall survival was similar. • Time to EGFR-TKI treatment failure was similar. • No difference in the intracranial failure patterns and cause. Brain metastasis (BM) is common in patients with epidermal growth factor receptor (EGFR)-mutant lung cancer. However, the brain surveillance strategy during treatment in advanced lung cancer patients varies, and the impact on clinical outcome is unclear. Here we aimed to evaluate the effect of different brain surveillance strategies on the clinical characteristics and treatment outcome in patients with EGFR-mutant lung adenocarcinoma treated with first-line EGFR tyrosine kinase inhibitors (EGFR-TKIs). This is a retrospective observational study conducted in a medical center in an area with high prevalence of EGFR mutation. Patients with initially diagnosed stage IV EGFR-mutant lung adenocarcinoma were included. Patients undergoing regular brain magnetic resonance imaging (MRI) every 3-6 months were categorized in the regular follow-up (RFU) group, and the rest were categorized in the liberal follow-up (LFU) group. Clinical outcomes were collected and analyzed. A total of 310 patients were included, and 43.5% initially had brain metastases. Patients in the LFU group were significantly older than those in the RFU group (median age: 67 vs 62, p < 0.001). The overall survival and time-to-treatment failure of patients with initial EGFR-TKIs treatment showed no statistical difference between the two groups. However, the intracranial progression free survival was significantly shorter in the RFU group than in the LFU group (p = 0.009). The risk of mortality was similar in the LFU and RFU groups. There was no difference in the intracranial progression patterns and cause of death between the two groups. For EGFR-mutant lung adenocarcinoma patients who used EGFR-TKIs as the frontline therapy, regular or liberal brain MRI follow-up showed no significant impact on the outcome, irrespective of initial brain metastasis. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results